{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:41:27Z","timestamp":1775594487373,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ijwd.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T23:57:15Z","timestamp":1593561435000},"page":"268-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature"],"prefix":"10.1097","volume":"6","author":[{"given":"Daniel","family":"Kwak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearl E.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"12","key":"10.1016\/j.ijwd.2020.06.009_b0005","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2020.06.009_b0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1346-8138.2012.01591.x","article-title":"Hydroxychloroquine-induced hyperpigmentation","volume":"39","author":"Cho","year":"2012","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2020.06.009_b0015","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1503\/cmaj.150622","article-title":"Hydroxychloroquine-related skin discoloration","volume":"189","author":"Coulombe","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.ijwd.2020.06.009_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12105-011-0288-5","article-title":"Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine","volume":"6","author":"de Melo Filho","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"7","key":"10.1016\/j.ijwd.2020.06.009_b0025","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1111\/j.1365-2230.2008.03185.x","article-title":"Drug-induced pigmentation of hard palate and skin due to chronic chloroquine therapy: report of two cases","volume":"34","author":"Gallo","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.ijwd.2020.06.009_b0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijwd.2020.06.009_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D31912020723","article-title":"Hydroxycholoroquine-induced hyperpigmentation","volume":"19","author":"Mir","year":"2013","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.ijwd.2020.06.009_b0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaad.2017.03.027","article-title":"The quinacrine experience in a population of cutaneous lupus erythematosus and dermatomyositis patients","volume":"77","author":"Mittal","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.ijwd.2020.06.009_b0045","doi-asserted-by":"crossref","DOI":"10.5070\/D32T07Q0NW","article-title":"Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation","volume":"15","author":"Morrison","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ijwd.2020.06.009_b0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.ijwd.2020.06.009_b0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/03009740701769735","article-title":"Hyperpigmentation of the skin due to hydroxychloroquine","volume":"37","author":"Rood","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.ijwd.2020.06.009_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3899\/jrheum.140995","article-title":"Hydroxychloroquine-induced hyperpigmentation of the skin","volume":"42","author":"Sawalha","year":"2015","journal-title":"J Rheumatol"},{"issue":"6778","key":"10.1016\/j.ijwd.2020.06.009_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(53)90138-X","article-title":"Lupus erythematosus treated with chloroquine","volume":"265","author":"Shee","year":"1953","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijwd.2020.06.009_b0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3949\/ccjm.85a.17034","article-title":"Hydroxychloroquine: an old drug with new relevance","volume":"85","author":"Shippey","year":"2018","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"10.1016\/j.ijwd.2020.06.009_b0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/15569527.2010.521225","article-title":"Antimalarial cutaneous side effects: a study in 209 users","volume":"30","author":"Skare","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"issue":"4","key":"10.1016\/j.ijwd.2020.06.009_b0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1963.01590220051006","article-title":"Pigmentation from antimalarial therapy: its possible relationship to the ocular lesions","volume":"88","author":"Tuffanelli","year":"1963","journal-title":"Arch Dermatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647520301064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647520301064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T12:00:05Z","timestamp":1667217605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647520301064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2352647520301064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2020.06.009","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}